CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.

Tanuja Narayansamy GengiahQuarraisha Abdool KarimIshana HarkooLeila MansoorNonhlanhla Yende ZumaPrecious RadebeNatasha SamsunderCheryl BaxterB MaharajMarc M BaumJohn A MossBruno PozzettoCatherine HankinsSalim Abdool Karim

Published in: BMJ open (2022)

PACTR201809520959443.

Keyphrases

clinical trial
study protocol
open label
double blind
phase ii
polycystic ovary syndrome
randomized controlled trial
placebo controlled
phase iii
pregnancy outcomes
antiretroviral therapy
soft tissue
cervical cancer screening
adipose tissue
breast cancer risk
pregnant women
insulin resistance
metabolic syndrome